Clinical Trial Update: Novel Therapeutics and Endothelial Dysfunction in T1DM Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating novel therapeutics targeting endothelial dysfunction in adults with Type 1 diabetes mellitus, focusing on biomarkers, end…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Type 1 Diabetes Mellitus

Drugs mentioned

• Incretins (incretins)
• SGLT-2 inhibitors

Snippet

Sponsor: General and Teaching Hospital Celje | Conditions: Endothelial Dysfunction, Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED